The Frequency of COVID-19 Infection in Psoriasis Patients Treated with Immunosuppressive and Immunomodulatory Drugs

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Poostiyan Nazila; Shahmoradi Zabiholah; Shafiee Amir

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Isfahan Medical School Year:2023 | Volume:41 | Issue:722 Page(s): 438-445

Download Full-Text

Persian Verion

View:

Download:

Cites:

Information Journal Paper

Title

The Frequency of COVID-19 Infection in Psoriasis Patients Treated with Immunosuppressive and Immunomodulatory Drugs

Author(s)

Poostiyan Nazila | Shahmoradi Zabiholah | Shafiee Amir | Issue Writer Certificate

Keywords

COVID-19Q4

HospitalizationQ4

Immunosuppressive agentsQ4

ImmunomodulationQ4

PsoriasisQ4

Abstract

Background: Psoriasis patients treated with immunosuppressive and immunomodulatory drugs are at higher risk of infections, as infections can also trigger Psoriasis. The aim of this study is to investigate the rate of COVID-19 infection with different severity of symptoms in Psoriasis patients treated with immunosuppressive and immunomodulatory drugs. Methods: This cross-sectional study was conducted during the summer of 2021 in Isfahan city. The studied population comprised Psoriasis patients with electronic medical records in Siddiqa Tahereh Medical Center and Al-Zahra Hospital. Phone interviews were conducted with patients to gather information on the duration of Psoriasis disease, drug used, dosage, history of COVID-19 infection, disease severity (hospitalization, mortality) and the recurrence or exacerbation of Psoriasis following COVID-19 infection. Findings: 38% of Psoriasis patients treated with immunosuppressive and immunomodulatory drugs were infected with COVID-19, 75% were outpatients and 23.5% were hospitalized. Of the psoriatic patients, 39% treated with Methotrexate (MTX), 40% treated with Adalimumab, and 48% treated with Infliximab reported a history of COVID-19 disease. Psoriasis recurrence following COVID-19 was observed in 22% of patients. The most history of infection with COVID-19 was reported in Psoriasis patients treated with Infliximab, Adalimumab, and MTX, respectively. Conclusion: By suppressing the immune system and reducing its function, immunosuppressive and immunomodulatory drugs can directly increase COVID-19 risk and severity in Psoriasis patients.

Cites

No record.

References